Sequoia Capital Israel

Sequoia Capital Israel is a venture capital firm that backs startups and growth companies across seed to late-stage rounds, with a focus on Israel. It invests across sectors including fintech, financial services, internet, mobile, technology, and healthcare, spanning banking, payments, advertising, ecommerce, data, security, software, and related enabling tech. Typical commitments range from 100,000 to 1 million in seed, 1 to 10 million in early venture, and 10 to 100 million in growth rounds. The firm is based in Tel Aviv and operates as part of Sequoia Capital's global network.

Rohit Agarwal

Vice President and Principal

Helen Fan

Vice President

Fu Xin

Partner

Marie Klemchuk

CFO

Shmil Levy

Investor

Past deals in North America

Nirmata

Venture Round in 2025
Nirmata develops a platform that simplifies the management of containerized applications. It offers Kubernetes-as-a-Service for automated operations, application modernization for containerization, and multi-cloud cluster management to ensure portability across different cloud providers. Its solutions are widely used by Kubernetes users, particularly in regulated industries.

Atomicwork

Series A in 2025
Founded in 2022, Atomicwork is a San Francisco-based company specializing in modern service management software. Its platform integrates with popular tools like Microsoft Teams and Slack, enabling employees to resolve IT issues directly from these platforms without needing to access separate portals.

Normunity

Series B in 2025
Normunity is a biotechnology company that develops precision immuno‑oncology medicines, termed immune normalizers, designed to restore the body’s natural immune response against cancer. Leveraging a partnership with Dr. Lieping Chen’s laboratory at Yale School of Medicine, the company focuses on newly discovered mechanisms of immune disruption, such as the exclusion of T‑cells from immune‑sensitive tumors and other barriers to normal immune function. Its pipeline includes programs targeting these mechanisms to enable clinicians to treat cancer by reactivating the patient’s own immunity. Normunity operates from offices in Boston, Massachusetts, and West Haven, Connecticut.

Twin Health

Series D in 2023
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Spear Bio

Seed Round in 2023
Spear Bio is a biotechnology company based in Weston, Massachusetts, founded in 2021. The company specializes in ultrasensitive protein detection technology, which significantly enhances healthcare diagnostics. Its innovative approach enables the quantification of minute protein biomarkers from samples collected at home, facilitating self-testing and telemedicine applications. By allowing clinicians to detect these biomarkers from small sample volumes, Spear Bio's technology integrates seamlessly into existing workflows for sample collection, processing, and detection, thereby improving the overall efficiency of healthcare delivery.

Triple-A

Series A in 2023
Triple-A facilitates seamless business payments in both traditional and digital currencies. Licensed by the Monetary Authority of Singapore (MAS) and other regulatory bodies, Triple-A offers secure, compliant payment solutions via API or no-code integration, serving over 20,000 businesses worldwide.

Sigmoid

Series B in 2022
Sigmoid is a Data Solutions company offering best-in-class services in Data Engineering and Data Science. With over 110 team members driven by a passion for unraveling data complexities, Sigmoid generates actionable insights and translates them into successful business strategies. The company leverages expertise in Open Source and Cloud Technologies to develop innovative frameworks tailored to specific client needs, positively influencing the performance of Fortune 1000 clients worldwide.

LegalOn Technologies

Series D in 2022
LegalOn is an AI-driven platform specializing in contract review. It leverages AI, legal content, and team knowledge to identify potential risks, suggest redlines, and structure contract data, thereby enhancing efficiency in legal processes.

NuProbe

Series B in 2022
NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

BUD

Series B in 2022
Founded in 2019 by former Snap engineers, BUD is a Singapore-based company building an open metaverse gaming platform. It connects millions of user-generated virtual worlds created by its community of creators. Since its launch in November 2021, BUD has become a top social app in over 38 countries, facilitating the creation and trade of millions of 3D content.

Afriex

Series A in 2022
Afriex Inc. is a mobile payment application developer based in Oakland, California, specializing in overseas money transfer services. Founded in 2019, the company offers a digital wallet application that allows users to send and receive money globally, utilizing stablecoins to ensure fast and cost-effective remittance solutions. Afriex supports transactions to over 30 countries, enabling users to make payments and manage their finances more efficiently at current exchange rates, while also providing various withdrawal options to enhance the user experience.

Last9

Series A in 2022
Last9 is a technology company that provides a site reliability engineering (SRE) platform and incident management solution for distributed systems. The platform helps engineering and DevOps teams gain visibility into system performance, define and adopt service level objectives, and ship reliable software faster by reducing the guesswork in improving reliability. Founded in 2020, Last9 focuses on enabling teams to understand, diagnose, and respond to incidents across complex, distributed architectures.

Inceptio Technology

Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Vymo

Series C in 2022
Vymo is a leading provider of a sales engagement platform tailored to enhance sales productivity and effectiveness for financial institutions. The platform addresses over 18 industry-specific use cases for frontline personnel, sales managers, and business leaders through intelligent prompts and customized playbooks. Major global enterprises such as Berkshire Hathaway, Aflac, BNP Paribas, AIA, Generali, and Sunlife Financial have implemented Vymo to provide actionable insights to executives and their teams. The platform is recognized by Gartner as a market leader in sales engagement solutions.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia, designed to connect small businesses seeking loans with lenders looking to fund these loans. By leveraging technology, Modalku offers borrowers access to financing options that may not be available through traditional channels, often at lower interest rates. Lenders participating in the platform can achieve returns that surpass those typically found in bank deposits and traditional investment products. This marketplace lending model has been successfully implemented in various countries, including the USA, UK, China, and Singapore, demonstrating its effectiveness in supporting small business growth.

Airmeet

Series B in 2022
Airmeet operates an immersive virtual events platform for event organizers, marketers, community builders, and enterprises. Its scalable platform supports various event formats such as fairs, expos, meetups, workshops, summits, and town halls.

Chargebee

Series H in 2022
Chargebee provides subscription and recurring billing solutions for SaaS, eCommerce, and membership services. Its platform handles subscription management, recurring billing, pricing and payment optimization, revenue recognition, collections, and customer retention to help businesses grow recurring revenue. It supports promotions, custom fields, and custom domains, with mobile-friendly checkout and a robust REST API for integration. The offering includes RevenueStory analytics to enable data-driven revenue decisions across the organization. The company serves global customers and provides professional support to help implement best practices and compliance. Headquartered in California, it maintains additional offices in Los Angeles and Chennai, reflecting its international presence.

Zuper

Series A in 2022
Zuper, Inc. is an information technology company based in Sammamish, Washington, founded in 2016. It specializes in developing a comprehensive field service management platform that enhances collaboration and efficiency for field and remote workforces. The platform provides a suite of tools including work order management, intelligent scheduling, timesheet management, live location tracking, and estimation software. Zuper's solution is designed to integrate seamlessly with various applications and customer relationship management systems, allowing organizations in industries such as cleaning, electrical, plumbing, internet services, and landscaping to optimize their operations. By modernizing field operations, Zuper helps service businesses expand rapidly while improving customer experiences through robust reporting and analytics.

Shoplazza

Series C in 2022
Shoplazza is an award-winning shopping cart commerce technology company founded in 2017, based in North America with its global strategy department headquartered in Toronto. The company offers an all-in-one eCommerce platform that simplifies the process of starting, marketing, and managing online stores of any size. Powered by advanced technology, Shoplazza ensures reliability, scalability, and adaptability, enabling merchants to create a headless commerce experience. The platform supports various shopping scenarios, empowering global merchants to cultivate a direct relationship with their customers while building and owning their brand. Additionally, Shoplazza's Direct-to-Customer branding incubation team assists merchants throughout their entire buyer journey, fostering memorable and distinctive brand identities.

Clari

Series F in 2022
Clari Inc. is a revenue operations platform based in Sunnyvale, California, founded in 2012. The company utilizes automation and artificial intelligence to consolidate and analyze activity data from various business systems, such as CRM, email, calendar, and marketing automation. This integration provides sales professionals with improved visibility into their deals and relationships, enabling them to close deals more efficiently and reduce manual reporting efforts. Clari's platform offers features like Activity Analytics, which delivers predictive insights and real-time data analysis, allowing sales teams and managers to optimize their strategies, enhance coaching, and effectively allocate resources. By streamlining revenue operations, Clari assists B2B companies, including notable clients like Qualtrics and Adobe, in forecasting business performance, managing pipelines, and minimizing customer churn.

Personetics

Private Equity Round in 2022
Personetics Technologies Ltd. is a provider of customer interaction technology designed specifically for the financial services sector. Founded in 2010 and headquartered in White Plains, New York, the company also has a research and development center in Nazareth, Israel, and additional offices in Tel Aviv, Israel, and Singapore. Personetics offers a range of solutions, including the Personetics Digital Banker, which facilitates customer-centric processes across various digital channels, and Personetics Anywhere, which enables personalized assistance through messaging platforms. The company’s Self-Driving Finance platform engages retail and small business customers by providing tailored guidance in financial management. By leveraging real-time analytics and a library of banking-specific predictions, Personetics empowers financial institutions to enhance customer experiences, convert passive users into active participants, and streamline operations.

Hevo Data

Series B in 2021
Hevo Data Inc. is a software-as-a-service company specializing in data integration services. Founded in 2016, the company has developed a platform that allows users to connect and transfer data between various sources and destinations, including databases, cloud storage, and applications. Hevo's platform also facilitates data analysis across multiple formats and silos, catering to a diverse range of industries such as fintech, hospitality, e-commerce, healthcare, and edtech. Headquartered in San Francisco, California, Hevo Data also maintains an office in Bengaluru, India, enhancing its global reach and operational capabilities.

Course Hero

Series C in 2021
Course Hero operates as an online learning platform dedicated to providing study resources for students and educators. Founded in 2006 and based in Redwood City, California, the company offers a range of materials including lecture notes, study guides, textbook help, practice problems, exams, and video lectures from universities across the United States and internationally. Course Hero's platform is subscription-based and includes an educator platform for distributing materials and publishing content. Additionally, it features a flashcards application and access to expert tutors who assist students with their queries. The company was previously known as TheCollegeFreeway.

ABclonal

Series D in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Drip Capital

Series C in 2021
Drip Capital Inc. is a financial technology company that specializes in providing credit solutions to small and medium enterprises (SMEs) engaged in cross-border trade, particularly in developing markets. Founded in 2014 and headquartered in Palo Alto, California, with an additional office in Mumbai, India, Drip Capital offers a range of trade finance products, including invoice factoring, export finance, and receivables factoring. The company utilizes an automated risk assessment model to facilitate quick and hassle-free access to financing, thus streamlining the borrowing process for its clients. Drip Capital's platform leverages multiple data sources for underwriting transactions, enabling SMEs to obtain collateral-free loans and lines of credit to support their working capital needs. The team comprises experienced professionals from prestigious institutions, and the company is supported by notable investors from Silicon Valley.

Animoca Brands

Venture Round in 2021
Animoca Brands is a venture capital firm focused on driving digital property rights to gamers and internet users through non-fungible tokens (NFTs). It leverages gamification and blockchain technology to develop, market, and invest in mobile applications, games, and additional products centered around educational learning, ensuring transparency, security, and new business models.

Twin Health

Series C in 2021
Twin Health, Inc. is a precision health company that focuses on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in Chennai and Bengaluru, India, the company utilizes artificial intelligence and Internet-of-Things technologies to assess and restore metabolic health. Its platform analyzes complex biosignals from wearable sensors to predict metabolic outcomes and provide tailored treatment recommendations based on individual metabolic profiles. Twin Health has developed unique technology, with several patents granted and pending, that underpins its mission to normalize blood sugar levels and reduce reliance on medications.

Clarisights

Series A in 2021
Clarisights is a data ingestion and analytics platform founded in 2018 and based in Palo Alto, California. The company aims to empower performance marketing and growth teams by providing tools for independent exploration and analysis of data from various sources. By integrating with multiple data channels, Clarisights allows marketers to create and optimize dashboards, collaborate with teammates, and analyze data in real time without the need for complex configurations or data pipelines. The platform offers a seamless in-browser experience where users can quickly build interactive visualizations to gain insights into their marketing efforts, such as identifying major sources of traffic and analyzing the effectiveness of advertising campaigns. Clarisights serves as an essential tool for marketing teams globally, facilitating efficient data management and decision-making in performance marketing workflows.

Cellular Biomedicine Group

Series A in 2021
Cellular Biomedicine Group, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer and stem cell therapies for degenerative diseases in Greater China. The company employs proprietary cell-based technologies, including various forms of CAR-T therapy, which targets different cancer types, and human adipose-derived mesenchymal progenitor cells aimed at treating joint diseases. Its product pipeline features therapies such as CD20 and CD22 CAR-T for B cell malignancies, and alpha fetoprotein TCR-T targeting hepatocellular carcinoma. Additionally, Cellular Biomedicine is developing knee osteoarthritis treatments, including AlloJoin and Re-Join, the latter having completed Phase IIb trials. The company also engages in broader biopharmaceutical activities, encompassing research and development, technical support, and manufacturing of pharmaceutical polypeptides and medical devices. It has established a partnership with Novartis Pharma AG to produce and supply the CAR-T cell therapy Kymriah in China. Founded in 2001, Cellular Biomedicine Group is headquartered in New York, New York, and draws on a wealth of cellular medicine research and expertise from scientists and clinicians across the United States, England, and China.

Outer

Series B in 2021
Outer, Inc. is a direct-to-consumer company based in Santa Monica, California, specializing in the manufacture of outdoor furniture. Founded in 2017 and originally known as Jia Outdoor, Inc., the company rebranded in 2018 to better reflect its mission of enhancing outdoor living. Outer designs its products with input from experienced furniture designer Terry Lin and produces them in a family-owned factory led by CEO Jiake Liu. The company focuses on creating durable, eco-conscious furniture from sustainable materials, ensuring that its offerings can withstand harsh outdoor conditions. Since its inception, Outer has experienced significant growth, increasing its revenue elevenfold by 2020 and expanding its workforce substantially in a short period.

XtalPi

Series D in 2021
XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.

dMed

Series C in 2021
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Netskope

Venture Round in 2021
Netskope is a cloud security company that provides a SaaS-based platform offering real-time data and threat protection for enterprises worldwide. Its key products include Netskope Security Cloud, Cloud XDTM, NewEdge security network, CASB, SWG, and professional services. Serving various industries such as financial services, government, healthcare, high-tech, manufacturing, and retail, Netskope enables secure access to cloud services, websites, and private applications from any device.

ServiceTitan

Series G in 2021
ServiceTitan is a cloud-based software provider for field service businesses, offering tools to streamline operations, enhance customer service, and drive growth. Its platform caters to industries such as HVAC, plumbing, electrician services, and more in the United States and Canada.

LocoNav

Series B in 2021
LocoNav offers an online fleet management software platform that unifies fleet operations into a single system. The software provides GPS tracking, telematics, video safety, fuel monitoring, and analytics with alerts to monitor vehicle speed, direction, and events. By enhancing visibility and real-time decision making, it helps vehicle owners, businesses, and transporters improve security, optimize operations, and reduce costs. Founded in 2015 and headquartered in San Francisco, LocoNav focuses on delivering a cohesive platform to run and manage modern fleets.

Insilico Medicine

Series C in 2021
Insilico Medicine, Inc. is a biotechnology company that leverages artificial intelligence (AI) to transform drug discovery, biomarker development, and aging research. Founded in 2014 and based in Baltimore, Maryland, the company has established itself as a pioneer in applying advanced AI techniques, such as generative adversarial networks and reinforcement learning, to create novel molecular structures for various diseases, including cancer and age-related conditions. Insilico Medicine operates an integrated platform that covers all stages of drug discovery, from initial research to clinical trial analysis. Its projects include Pharma.AI, which offers machine learning services to various sectors, and Young.AI, a platform focused on aging predictors. The company also pursues internal drug discovery initiatives targeting diseases like Alzheimer's and Parkinson's, and has partnered with Life Extension to produce nutraceutical products utilizing deep learning and bioinformatics. Additionally, Insilico Medicine provides consumer applications aimed at enhancing health and longevity.

Slintel

Series A in 2021
Slintel Inc. is a technology company that provides a platform designed to enhance conversion rates for businesses by uncovering active buyers within their target markets. Founded in 2016 and based in Mountain View, California, Slintel analyzes over 100 billion data points to capture technographic-powered buying intent. Its platform evaluates buyer journeys, technology adoption patterns, and other digital footprints, offering market and sales intelligence. Users can access buying patterns and contact information for more than 17 million companies and 70 million decision-makers globally. By employing predictive algorithms, Slintel enables clients to identify and connect with high-intent buyers, facilitating more informed decision-making and targeted outreach.

Outreach

Series G in 2021
Outreach is a sales engagement platform that helps organizations manage and optimize interactions across email, voice, and social channels throughout the customer lifecycle. The platform uses machine learning to guide sales representatives to take the right actions, automate repetitive tasks, and personalize communications while tracking sales activity and performance. It supports account-based, outbound, and inbound sales, as well as sequence and task management, email and activity tracking, and insights that analyze buyer sentiment to optimize content and sequences in real time. By integrating automated alerts, collaboration features, and performance analytics, Outreach aims to increase the volume of qualified meetings and improve the efficiency and effectiveness of customer-facing teams.

Forter

Series F in 2021
Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

Phanes Therapeutics

Series B in 2021
Phanes Therapeutics is a biotechnology company specializing in drug discovery for immuno-oncology and eye diseases. Established in 2016, the company focuses on developing monoclonal antibodies for solid tumors and conditions like age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. Additionally, they work on bispecific antibodies targeting small cell lung cancer.

EdiGene

Series B in 2021
EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

Benchling

Series E in 2021
Benchling, Inc. delivers a cloud-based informatics platform for life sciences research and development. The platform unifies experiment design, data capture, and collaboration in a single interface, enabling scientists to design, record, and share experiments. It consists of an integrated lab notebook, a biological registration system to track inventory such as plasmids, antibodies, and cell lines, and a molecular biology design and analysis suite that supports end-to-end R&D workflows. Additional modules include Benchling Insights for querying and visualizing structured data and collaboration around it, and Bioregistry for biological entity registration and strain management. Benchling serves researchers in biotechnology and pharmaceutical companies as well as academic and government labs, including research and development managers and principal investigators who need centralized data management and streamlined collaboration. The platform is applied across antibodies, cell therapy, gene therapy, proteins and peptides, vaccines, and industrial biotechnology. Founded in 2012 and based in San Francisco, Benchling enables scientists to design DNA, manage workflows, and accelerate decision-making throughout the R&D lifecycle.

PackGene Biotech

Series C in 2021
PackGene Biotech is a United States-based contract research organization and contract development and manufacturing organization that specializes in viral vectors for gene therapies. The company focuses on adeno-associated virus (AAV) vector design, cloning and packaging, as well as production of AAV, lentiviral vectors, mRNA, and plasmid DNA. It serves early-stage drug discovery, preclinical development, and cell and gene therapy trials, delivering scalable, cost-effective production with emphasis on purity, titer and infectivity. PackGene offers customized vector design, construction, and packaging services to support researchers in accelerating gene therapy programs.

Plus

Series D in 2021
Plus is a global technology company headquartered in Silicon Valley that develops highly automated and fully autonomous driving solutions. Its open‑autonomy platform powers commercial vehicles in the United States and Germany and is used by leading automakers, fleets, and technology partners worldwide. The company focuses on making driving safer, more comfortable, and more sustainable, and it has been recognized by Forbes, Fast Company, Insider, CES, and AUVSI for its innovative technology. Plus also builds AI‑driven autonomous driving software for trucks, leveraging large AI models and generative AI to enable safe, affordable, and scalable deployment of autonomous freight vehicles.

ServiceTitan

Series F in 2021
ServiceTitan is a cloud-based software provider for field service businesses, offering tools to streamline operations, enhance customer service, and drive growth. Its platform caters to industries such as HVAC, plumbing, electrician services, and more in the United States and Canada.

ABclonal

Series C in 2021
ABclonal Inc. is a life science research and diagnostic reagents provider based in Woburn, Massachusetts, founded in 2016. The company specializes in offering a variety of biological research agents and services, including next generation sequencing library preparation kits, molecular biology products, catalog antibodies, catalog proteins, ELISA kits, and western blot tools and reagents. In addition to its extensive product range, ABclonal provides customized services related to peptides, antibodies, and proteins. The company distributes its products through a network of distributors across Europe, Asia, North America, and Oceania, aiming to enhance the quality of life science research with its high-quality offerings.

Outer

Series A in 2021
Outer, Inc. is a direct-to-consumer company based in Santa Monica, California, specializing in the manufacture of outdoor furniture. Founded in 2017 and originally known as Jia Outdoor, Inc., the company rebranded in 2018 to better reflect its mission of enhancing outdoor living. Outer designs its products with input from experienced furniture designer Terry Lin and produces them in a family-owned factory led by CEO Jiake Liu. The company focuses on creating durable, eco-conscious furniture from sustainable materials, ensuring that its offerings can withstand harsh outdoor conditions. Since its inception, Outer has experienced significant growth, increasing its revenue elevenfold by 2020 and expanding its workforce substantially in a short period.

NuProbe

Series B in 2021
NuProbe is a genomics and molecular diagnostics company that develops a platform of reagents and genetic toehold probes for noninvasive nucleic acid profiling. Their Sample‑In Answer‑Out solution integrates cell‑free DNA extraction, qPCR, sequencing and bioinformatics to detect mutations, CNVs, gene fusions and low‑frequency variants with high sensitivity. Founded in 2016, the company operates from Cambridge, Massachusetts and Shanghai, China, and focuses on early detection of cancer and infectious diseases for clinical and research use.

dMed

Series C in 2020
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Virta Health

Series D in 2020
Virta Health is a San Francisco–based health technology company that specializes in treating type 2 diabetes through an online, physician-supported program. The company combines nutritional biochemistry, data science, and digital tools to deliver on-demand care via a continuous remote care platform, providing physicians and health coaches who guide patients to reduce blood sugar and lose weight without medications or surgery. Founded in 2014, Virta offers a treatment approach aimed at reversing type 2 diabetes and improving related metabolic and cardiovascular health.

Olive

Venture Round in 2020
Olive AI, Inc. specializes in developing artificial intelligence and robotic process automation solutions tailored for healthcare organizations. Founded in 2012 and based in Columbus, Ohio, the company offers an AI-as-a-Service platform that automates a variety of administrative workflows, including claim status checks, account updates, and prior authorizations. By streamlining these repetitive and high-volume tasks, Olive allows healthcare professionals to focus on more creative and empathetic aspects of patient care. The software acts as an intermediary between different systems and data, helping to reduce administrative errors and improve cash collections, ultimately enhancing overall efficiency and patient outcomes in the healthcare sector. Olive AI, Inc. was previously known as CrossChx, Inc. before rebranding in July 2018.

Forter

Series E in 2020
Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

VanTop Group

Series A in 2020
VanTop Group is an Internet technology company headquartered in Shenzhen, with subsidiaries in the United States, Hong Kong, Europe, and Japan. The company focuses on independent research and development, emphasizing product innovation in the consumer electronics sector. VanTop specializes in the development and retail of smart electronic devices, including projectors, tablets, drones, and smart home products. With a mission to "Explore the Beauty of Life," VanTop aims to establish itself as a leading global consumer brand by leveraging globalization, branding operations, technological advancements, and localized strategies to deliver high-quality products to consumers worldwide.

PackGene Biotech

Series B in 2020
PackGene Biotech is a United States-based contract research organization and contract development and manufacturing organization that specializes in viral vectors for gene therapies. The company focuses on adeno-associated virus (AAV) vector design, cloning and packaging, as well as production of AAV, lentiviral vectors, mRNA, and plasmid DNA. It serves early-stage drug discovery, preclinical development, and cell and gene therapy trials, delivering scalable, cost-effective production with emphasis on purity, titer and infectivity. PackGene offers customized vector design, construction, and packaging services to support researchers in accelerating gene therapy programs.

Slintel

Series A in 2020
Slintel Inc. is a technology company that provides a platform designed to enhance conversion rates for businesses by uncovering active buyers within their target markets. Founded in 2016 and based in Mountain View, California, Slintel analyzes over 100 billion data points to capture technographic-powered buying intent. Its platform evaluates buyer journeys, technology adoption patterns, and other digital footprints, offering market and sales intelligence. Users can access buying patterns and contact information for more than 17 million companies and 70 million decision-makers globally. By employing predictive algorithms, Slintel enables clients to identify and connect with high-intent buyers, facilitating more informed decision-making and targeted outreach.

EdiGene

Series B in 2020
EdiGene Inc. is a biotechnology company specializing in the development of genome editing technologies for therapeutic applications in cancer and various genetic diseases. Founded in 2015 and headquartered in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts, EdiGene focuses on both ex vivo and in vivo gene-editing therapies. The company has established proprietary platforms for editing hematopoietic stem cells and T cells, as well as an RNA base editing approach for in vivo applications. EdiGene's innovative methods enable targeted modifications of genetic information in human cells and facilitate high-throughput drug discovery through advanced screening techniques. By translating these technologies into novel therapeutics, EdiGene aims to improve the safety and efficacy of gene therapy, ultimately benefiting patients, the pharmaceutical industry, and the scientific research community.

Shoplazza

Series B in 2020
Shoplazza is an award-winning shopping cart commerce technology company founded in 2017, based in North America with its global strategy department headquartered in Toronto. The company offers an all-in-one eCommerce platform that simplifies the process of starting, marketing, and managing online stores of any size. Powered by advanced technology, Shoplazza ensures reliability, scalability, and adaptability, enabling merchants to create a headless commerce experience. The platform supports various shopping scenarios, empowering global merchants to cultivate a direct relationship with their customers while building and owning their brand. Additionally, Shoplazza's Direct-to-Customer branding incubation team assists merchants throughout their entire buyer journey, fostering memorable and distinctive brand identities.

Shoplazza

Series B in 2020
Shoplazza is an award-winning shopping cart commerce technology company founded in 2017, based in North America with its global strategy department headquartered in Toronto. The company offers an all-in-one eCommerce platform that simplifies the process of starting, marketing, and managing online stores of any size. Powered by advanced technology, Shoplazza ensures reliability, scalability, and adaptability, enabling merchants to create a headless commerce experience. The platform supports various shopping scenarios, empowering global merchants to cultivate a direct relationship with their customers while building and owning their brand. Additionally, Shoplazza's Direct-to-Customer branding incubation team assists merchants throughout their entire buyer journey, fostering memorable and distinctive brand identities.

XtalPi

Series C in 2020
XtalPi is a pharmaceutical technology company that applies quantum mechanics, artificial intelligence, and high-performance computing to accelerate drug discovery and development. Its Intelligent Digital Drug Discovery and Development platform weaves physics-based modeling with AI to increase efficiency, accuracy, and success rates at critical stages of R&D. The company offers tools for crystal structure prediction and determination, solid-state testing and analysis, and crystallization process development, as well as solid-state screening and evaluation, enabling faster optimization of drug candidates. XtalPi also provides drug design support for small molecules and collaboration options in antibody and peptide research, and offers platform-based AI model development and integration across pharmaceutical workflows. Founded in 2014, it is based in Cambridge, Massachusetts, with additional offices in China.

Airmeet

Series A in 2020
Airmeet operates an immersive virtual events platform for event organizers, marketers, community builders, and enterprises. Its scalable platform supports various event formats such as fairs, expos, meetups, workshops, summits, and town halls.

AccuMedical

Series B in 2020
AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Simcha Therapeutics

Series A in 2020
Simcha Therapeutics is a biopharmaceutical company focused on developing engineered cytokine immunotherapy for cancer treatment. Founded in 2018 and headquartered in New Haven, Connecticut, the company utilizes directed evolution to create novel cytokines that enhance the immune system's ability to combat diseases. Its lead program, ST-067, is a designer IL-18 cytokine that has demonstrated significant antitumor effects in animal models, both as a standalone treatment and in combination with anti-PD-1 checkpoint inhibitors. This innovative approach aims to provide patients with more effective immunotherapies, thereby improving their ability to fight cancer.

Hitomorrow

Series B in 2020
Hitomorrow is a Beijing-based company founded in 2012 that specializes in the import and distribution of ready-to-cook food products. The company offers a diverse range of fresh ingredients, including imported chilled beef, pork, chicken, and various flavored meats. Additionally, Hitomorrow sources seafood and other ingredients from around the world, including beef and mutton from Australia and New Zealand, Canadian Arctic shellfish, sweet shrimp, Alaska king crab, squid, and Argentine red shrimp. The company's focus on providing high-quality, fresh products aims to cater to the growing demand for convenient meal solutions globally.

ASR Microelectronics

Series D in 2020
ASR Microelectronics (Shanghai) Co., Ltd. is a semiconductor manufacturer specializing in chips for mobile intelligent communication terminals, navigation, and various consumer electronics. Founded in April 2015 and headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company develops products including smartphones, modems, and integrated system on chips (SoCs). ASR's research and development efforts are supported by teams based in the United States and South Korea, focusing on technological innovation across mobile communications, the Internet of Things, and smart handheld devices. The company boasts comprehensive capabilities in baseband platform development, particularly following its acquisition of Marvell's Mobile Business Unit in 2017, positioning itself as a key player in China's semiconductor landscape. ASR is dedicated to providing efficient technical support and product solutions across multiple communication standards, including 2G, 3G, and 4G technologies.

Obviously AI

Seed Round in 2020
Founded in 2018, Obviously AI develops a cloud-based platform that enables users to run complex predictions and analytics on their data by asking natural language questions, without requiring coding knowledge. The platform uses machine learning algorithms to interpret user queries, find relevant data, and generate accurate predictions.

Pony.ai

Series B in 2020
Founded in 2016, Pony.ai develops artificial intelligence software for autonomous mobility deployment, focusing on manufacturing automated vehicles and offering public-facing Robotaxi services. The company operates fully driverless robotaxis through the PonyPilot mobile app in major Chinese cities.

Netskope

Series G in 2020
Netskope is a cloud security company that provides a SaaS-based platform offering real-time data and threat protection for enterprises worldwide. Its key products include Netskope Security Cloud, Cloud XDTM, NewEdge security network, CASB, SWG, and professional services. Serving various industries such as financial services, government, healthcare, high-tech, manufacturing, and retail, Netskope enables secure access to cloud services, websites, and private applications from any device.

Samya.AI

Seed Round in 2020
Samya.AI, headquartered in Northbrook, Illinois, specializes in developing an artificial intelligence and machine learning SaaS platform for businesses. The company focuses on empowering Consumer Packaged Goods (CPG) enterprises by harnessing deep learning, probabilistic machine learning, and reinforcement learning techniques alongside domain expertise to drive revenue growth potential. Samya.AI's platform aims to outperform other solutions, offering significant value and operational scalability for CPG companies seeking to enhance profitability.

Eko Health

Venture Round in 2020
Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

RootPath Genomics

Series A in 2020
RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Digifin

Seed Round in 2019
Digifin is a digital banking startup that has a comprehensive digital account opening platform along with the back office solution. It aims at simplifying and speeding up the account opening process. It also streamlines business processes and provides customer insight with the intent to support customer loyalty and retention. It was founded in 2011 and is headquartered in Chennai, India with offices in the USA and UAE.

Quolum

Seed Round in 2019
Quolum is a software company that provides a spend management platform for enterprise SaaS. The solution connects to billing and expense systems to deliver a unified view of SaaS spend and usage, combining cost data with utilization to help control software expenditures. It tracks spend across payment channels and across standard and shadow apps, with compliance checks and alerts when vendor performance changes. The platform includes scorecards to document vendor engagement and a secure contracts locker for storing SaaS agreements. Benchmarks compare spend with peers, renewal timelines, departments, and workflows to identify savings. Quolum Spend Management enables discovery of SaaS apps, utilization reporting, and cost optimization recommendations, and supports visualization of SaaS inventories aligned with security and policy requirements. Founded in 2019 and based in Dublin, California, Quolum serves enterprises seeking to optimize their SaaS portfolios and reduce waste.

Juno

Seed Round in 2019
Juno is a cross-border banking platform that aims to give users across the world a high-yield account to grow their savings. Going live in the US, 2Juno is taking a radical approach towards creating an open and global banking system for everyone, regardless of their location or income. Juno was founded in 2019 and is headquartered in Singapore.

StreamNative

Seed Round in 2019
StreamNative is a company that develops a cloud-native event streaming platform based on Apache Pulsar, designed to facilitate real-time access to enterprise data. This platform allows organizations to manage high volumes of data as continuous streams, providing a unified view that integrates both historical and real-time information. By leveraging the architectural strengths of Apache Pulsar, StreamNative enables various industries, including gaming, financial services, and IoT, to transition from isolated legacy systems to a cohesive event streaming environment. The company was founded by a team of experienced contributors and committers from the Apache Pulsar community, who have extensive expertise in implementing scalable event streaming solutions. Headquartered in San Francisco, StreamNative also has offices in Beijing, Shanghai, and Shenzhen, China, extending its reach to a global clientele.

Vim

Series B in 2019
Vim Inc., established in 2015 and headquartered in San Francisco, specializes in a healthcare platform that facilitates online services for patients and healthcare providers. The company's core offerings include online appointment scheduling solutions and referral coordination services, aiming to streamline care delivery between patients and medical professionals. Vim connects health plans, patients, and providers across various sizes and systems, with the mission of enhancing affordable, high-quality healthcare through seamless data connectivity within clinical operations at the point of patient care.

Vymo

Series B in 2019
Vymo is a leading provider of a sales engagement platform tailored to enhance sales productivity and effectiveness for financial institutions. The platform addresses over 18 industry-specific use cases for frontline personnel, sales managers, and business leaders through intelligent prompts and customized playbooks. Major global enterprises such as Berkshire Hathaway, Aflac, BNP Paribas, AIA, Generali, and Sunlife Financial have implemented Vymo to provide actionable insights to executives and their teams. The platform is recognized by Gartner as a market leader in sales engagement solutions.

Drip Capital

Series B in 2019
Drip Capital Inc. is a financial technology company that specializes in providing credit solutions to small and medium enterprises (SMEs) engaged in cross-border trade, particularly in developing markets. Founded in 2014 and headquartered in Palo Alto, California, with an additional office in Mumbai, India, Drip Capital offers a range of trade finance products, including invoice factoring, export finance, and receivables factoring. The company utilizes an automated risk assessment model to facilitate quick and hassle-free access to financing, thus streamlining the borrowing process for its clients. Drip Capital's platform leverages multiple data sources for underwriting transactions, enabling SMEs to obtain collateral-free loans and lines of credit to support their working capital needs. The team comprises experienced professionals from prestigious institutions, and the company is supported by notable investors from Silicon Valley.

Biofourmis

Series B in 2019
Biofourmis is a biotechnology company based in Boston, Massachusetts, founded in 2015. It specializes in personalized care and therapies through the use of digital therapeutics. The company develops and delivers clinically validated software-based therapeutics that enhance patient outcomes. Biofourmis has created a predictive health analytics platform that analyzes physiology data gathered from clinical-grade wearables. Utilizing artificial intelligence, this platform integrates and interprets continuous physiological data to identify personalized patterns and predict potential clinical exacerbations. By enabling medical professionals to intervene days before critical events occur, Biofourmis aims to improve patient care and provide cost-effective solutions for healthcare providers.

Cullgen

Series A in 2019
Cullgen Inc. is a clinical-stage biopharmaceutical company developing small molecule therapeutics based on its uSMITE platform, which enables targeted protein degradation by using novel E3 ligands to selectively degrade disease-causing proteins. The approach aims to address cancers, inflammatory and autoimmune diseases, and other conditions lacking effective therapies. Founded in 2018 and based in San Diego, Cullgen's pipeline includes degrader programs such as TRK and GSPT1, as well as other candidates like DAC.

Band Protocol

Seed Round in 2019
Band Protocol is a cross-chain data oracle platform that securely connects real-world data and APIs to smart contracts. It enables blockchain developers to create reliable price feeds, event reports, and other data oracles for decentralized applications without relying on centralized sources.

VoxelCloud

Series B in 2018
VoxelCloud Inc. is a technology company specializing in cloud computing and artificial intelligence solutions aimed at enhancing the interpretation of medical images and clinical data. Founded in 2015 and headquartered in Los Angeles, California, VoxelCloud develops automated medical image analysis services that assist healthcare practitioners in diagnosing conditions such as lung cancer, diabetic retinopathy, coronary heart disease, and liver disease. Utilizing proprietary algorithms and deep learning techniques, the company provides accurate and timely insights, transforming clinical workflows and enabling evidence-based decision-making. In addition to its Los Angeles headquarters, VoxelCloud maintains offices in Shanghai and Suzhou, China, and has a satellite research and development team in Phoenix, further supporting its commitment to advancing healthcare through innovative technology.

Plus

Series A in 2018
Plus is a global technology company headquartered in Silicon Valley that develops highly automated and fully autonomous driving solutions. Its open‑autonomy platform powers commercial vehicles in the United States and Germany and is used by leading automakers, fleets, and technology partners worldwide. The company focuses on making driving safer, more comfortable, and more sustainable, and it has been recognized by Forbes, Fast Company, Insider, CES, and AUVSI for its innovative technology. Plus also builds AI‑driven autonomous driving software for trucks, leveraging large AI models and generative AI to enable safe, affordable, and scalable deployment of autonomous freight vehicles.

Silk

Corporate Round in 2018
Silk is a technology company that focuses on enhancing AI innovation by providing real-time access to production data in the cloud. It integrates high-performance cloud storage into AI workflows, allowing organizations to improve innovation while ensuring performance, reliability, and control over their enterprise data. Silk's agile data delivery system eliminates the need to copy production data, thereby increasing flexibility and enabling the utilization of production data for Generative AI applications. The company holds over 20 technology patents, which support its mission to help customers maximize the advantages of the public cloud with speed and ease. Silk is headquartered near Boston, Massachusetts.

Deep Intelligent Pharma

Series B in 2018
Beijing Deep Intelligent Pharma Technology Co., Ltd. specializes in leveraging artificial intelligence and blockchain technology to enhance drug discovery, development, and medical affairs for pharmaceutical companies. Founded in 2017 and based in Beijing, the company offers a range of products, including a multi-language medical machine translation engine, intelligent pharmacovigilance for risk management, and tools for creating multilingual educational materials. Deep Intelligent Pharma also provides AI-enabled solutions for medical writing, document review, and quality control, as well as a patient search ecosystem to facilitate medical and clinical research. Additionally, the company offers intelligent regulatory affairs solutions to streamline drug research and development processes. Operating globally, including in China, the United States, and Japan, Deep Intelligent Pharma aims to improve the efficiency and quality of the pharmaceutical development lifecycle.

Forter

Series D in 2018
Forter is a real-time, fully automated fraud prevention platform for online retailers. It delivers decisions on transactions through its end-to-end fraud prevention system, leveraging machine learning, cyber intelligence, elastic identity, and behavioral analysis to assess each transaction and the customer profile, with visibility through a dedicated dashboard. Its solutions include Decision-As-a-Service for transparent fraud decisions and Smart Routing to minimize revenue loss from false declines across web and mobile channels, enabling merchants to reduce fraud while supporting growth and improving the customer experience. Founded in 2013 and based in New York with offices in London and Tel Aviv, Forter's platform aims to automate transaction risk management and protect e-commerce from credit card fraud, account takeover, identity theft, and returns abuse.

RootPath Genomics

Seed Round in 2018
RootPath Genomics, Inc. is a biotechnology company founded in 2017 and headquartered in Cambridge, Massachusetts. The company specializes in developing a next-generation T-cell therapy platform that integrates precision medicine with cancer immunotherapy. By focusing on the analysis and manipulation of individual immune cells, RootPath aims to enhance immune responses and improve cell therapy efficacy. Its innovative technologies allow for precise monitoring and modulation of the immune system, which is intended to revolutionize the diagnosis and treatment of cancer.

Skyline AI

Series A in 2018
Skyline AI Ltd is a technology company specializing in artificial intelligence applications for the commercial real estate sector. Founded in 2017 and headquartered in New York, with an additional office in Tel Aviv, the company has developed a sophisticated platform that streamlines and digitizes the real estate investment process. This platform utilizes live data to forecast future rent and disposition prices, identify market trends, and locate properties with optimal risk-reward ratios. By leveraging both static and time series data from various sources, Skyline AI enhances due diligence, assesses risk and yield, and provides ongoing management and monitoring for investment opportunities. The company's advanced technology aims to simplify legal, tax, and financial aspects for both domestic and international investors, granting them access to institutional-grade commercial real estate opportunities.

Freshworks

Series G in 2018
Freshworks Inc. develops innovative software solutions designed to enhance customer engagement for businesses of all sizes. Founded in 2010 and headquartered in San Mateo, California, the company provides a suite of software-as-a-service products that cater to various business functions. Its offerings include Freshdesk for customer support, Freshsales CRM for sales management, Freshservice for IT service management, and Freshteam for recruitment and employee management. Additionally, Freshworks provides tools like Freshchat for customer interaction, Freshmarketer for marketing automation, and Freshcaller for cloud-based telephony. The company's solutions enable organizations to acquire, engage, and retain customers while offering a comprehensive view of customer interactions. Freshworks has a global presence with offices in multiple countries, including India, the UK, Australia, Germany, France, Singapore, and the Netherlands. Its commitment to delivering user-friendly software ensures a quick return on investment for its clients.

Farcast

Series C in 2018
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with operations in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the natural state of human tumors through the culture of fresh, unmodified tumor fragments, creating a human tumor microenvironment. Farcast's technology enables oncologists to evaluate individual tumors and predict patient response to treatments before initiating therapy. Additionally, it serves drug developers and researchers by providing accurate and precise models for testing and analysis, facilitating the development of personalized cancer therapies.

Pony.ai

Series A in 2018
Founded in 2016, Pony.ai develops artificial intelligence software for autonomous mobility deployment, focusing on manufacturing automated vehicles and offering public-facing Robotaxi services. The company operates fully driverless robotaxis through the PonyPilot mobile app in major Chinese cities.

Drip Capital

Series A in 2018
Drip Capital Inc. is a financial technology company that specializes in providing credit solutions to small and medium enterprises (SMEs) engaged in cross-border trade, particularly in developing markets. Founded in 2014 and headquartered in Palo Alto, California, with an additional office in Mumbai, India, Drip Capital offers a range of trade finance products, including invoice factoring, export finance, and receivables factoring. The company utilizes an automated risk assessment model to facilitate quick and hassle-free access to financing, thus streamlining the borrowing process for its clients. Drip Capital's platform leverages multiple data sources for underwriting transactions, enabling SMEs to obtain collateral-free loans and lines of credit to support their working capital needs. The team comprises experienced professionals from prestigious institutions, and the company is supported by notable investors from Silicon Valley.

Propeller Aero

Series A in 2018
Propeller Aero is a global leader in drone mapping and analytics solutions, headquartered in Sydney, Australia, with an additional office in Denver, USA. Founded in 2014 by Francis Vierboom and Rory San Miguel, the company provides innovative hardware and software products tailored for the construction, aggregates, mining, and waste management industries. Propeller's platform empowers worksites to measure and manage their operations effectively using user-friendly visual tools accessible from any device. This flexibility enhances worksite management efficiency and collaboration while helping to reduce costs and risks. Through its solutions, Propeller serves thousands of worksites worldwide, enabling teams to track, inspect, and report on job progress and productivity with accuracy and safety.

BITMAIN

Series B in 2018
Bitmain is a leading manufacturer of Bitcoin mining hardware, specializing in the development and sale of miners utilizing ASIC chip technology. Founded by pioneers in the digital currency sector, the company is staffed by a team of skilled engineers, financial experts, and cryptocurrency enthusiasts. Headquartered in Beijing, Bitmain also maintains offices in cities such as San Francisco, Tel Aviv, Hong Kong, Chengdu, and Shenzhen. The company focuses on providing high-quality, efficient computing solutions, including high-density server equipment and large-scale parallel computing software, to support the cryptocurrency mining industry.

Brii Biosciences

Venture Round in 2018
Founded in 2018, Brii Biosciences is a biotechnology company dedicated to researching, developing, and commercializing medicines for chronic illnesses, with a primary focus on infectious diseases. Headquartered in Durham, North Carolina, the company operates additional offices in Shanghai and Beijing, China; and San Francisco, California.

GRAIL

Series C in 2018
GRAIL focuses on developing technologies for early cancer detection. Founded in 2016, the company specializes in a pan-cancer screening test that measures circulating nucleic acids in blood using high-intensity sequencing.

Skyline AI

Seed Round in 2018
Skyline AI Ltd is a technology company specializing in artificial intelligence applications for the commercial real estate sector. Founded in 2017 and headquartered in New York, with an additional office in Tel Aviv, the company has developed a sophisticated platform that streamlines and digitizes the real estate investment process. This platform utilizes live data to forecast future rent and disposition prices, identify market trends, and locate properties with optimal risk-reward ratios. By leveraging both static and time series data from various sources, Skyline AI enhances due diligence, assesses risk and yield, and provides ongoing management and monitoring for investment opportunities. The company's advanced technology aims to simplify legal, tax, and financial aspects for both domestic and international investors, granting them access to institutional-grade commercial real estate opportunities.

SafeBreach

Series B in 2018
SafeBreach Inc. is a cybersecurity company that specializes in breach and attack simulation (BAS). Founded in 2014 and headquartered in Sunnyvale, California, with an additional office in Tel Aviv, Israel, SafeBreach offers a platform designed to enhance an organization's security posture by simulating real-world attack methods. The platform utilizes a comprehensive Hacker's Playbook, which includes a range of breach techniques derived from actual cyber incidents, to proactively identify vulnerabilities within an enterprise's network, cloud, and endpoints. By mimicking the tactics of cybercriminals, SafeBreach enables businesses to validate their security controls and improve the responsiveness of their security operations center (SOC) analysts. The platform can integrate with various security information and event management systems, ticketing solutions, and automation tools, providing continuous visibility into potential security threats and allowing organizations to address issues before they can be exploited by attackers.

Refuge Biotechnologies

Series B in 2018
Refuge Biotechnologies, Inc. is a biotechnology company focused on developing innovative cancer immunotherapies. Founded in 2015 and based in Menlo Park, California, the company utilizes advanced gene-editing technology, specifically CRISPR-dCas, to create cell therapies that are capable of sensing their environment and conditionally regulating multiple genes at once. This approach enables Refuge to enhance the potency and specificity of its treatments, allowing for more effective targeting of cancer cells compared to traditional therapies that focus on a single target. Through its research and development efforts, Refuge aims to unlock the full potential of cell therapies in the fight against cancer.

Shoplazza

Series A in 2018
Shoplazza is an award-winning shopping cart commerce technology company founded in 2017, based in North America with its global strategy department headquartered in Toronto. The company offers an all-in-one eCommerce platform that simplifies the process of starting, marketing, and managing online stores of any size. Powered by advanced technology, Shoplazza ensures reliability, scalability, and adaptability, enabling merchants to create a headless commerce experience. The platform supports various shopping scenarios, empowering global merchants to cultivate a direct relationship with their customers while building and owning their brand. Additionally, Shoplazza's Direct-to-Customer branding incubation team assists merchants throughout their entire buyer journey, fostering memorable and distinctive brand identities.

VIPKid

Series D in 2018
VIPKid is an education technology company that facilitates real-time online English immersion learning for children, primarily in China. Founded in 2013 and launched in 2014, VIPKid connects over 500,000 paying students with more than 60,000 teachers from the United States and Canada. The platform aims to provide an American elementary school experience, allowing Chinese students, especially those in remote areas, to learn English and gain a broader understanding of the world from their homes. VIPKid emphasizes personalized learning to cater to the unique needs of each student, fostering curiosity and cultural exchange. The company has established itself as a market leader in online education in China, attracting significant investments from notable venture capital firms.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.